Establishment method and application of HPLC fingerprint spectrum of lithospermum erythrorhizon hydroxyl naphthoquinone component

Segregation and analysis of seven hydroxynaphthoquinone components in purple grass by HPLC fingerprint method, solving the problem of difficulty in separation in the existing technology, achieving a more accurate and comprehensive evaluation of the quality of purple grass, and improving the detection accuracy and reliability.

CN118914419APending Publication Date: 2024-11-08DEJI (GUIZHOU) BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411073750.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing cypress analysis methods are difficult to separate the seven major hydroxynaphthoquinone components and establish index detection standards, making it difficult to accurately judge and evaluate the quality of cypress.

Method used

Using HPLC fingerprinting method, 7 hydroxynaphthoquinone components were separated and washed out with the mobile phase changes through acetonitrile-formic acid as the mobile phase, and their content was analyzed qualitatively and quantitatively to establish a more complete and accurate purplish quality evaluation system.

Benefits of technology

Multi-faceted detection of seven hydroxynaphthoquinone components in hard comfresh has been achieved, the quality detection system has been improved, and a reliable basis for the authenticity identification and internal quality of comfresh has been provided, and the accuracy and integrity of the detection have been improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118914419A_ABST
    Figure CN118914419A_ABST
Patent Text Reader

Abstract

The invention relates to an establishment method and application of an HPLC (High Performance Liquid Chromatography) fingerprint spectrum of a lithospermum erythrorhizon hydroxyl naphthoquinone component. The method comprises the following steps: (1) obtaining an extracting solution; (2) preparing a single control solution; (3) respectively taking the single control solutions, injecting the single control solutions into a liquid chromatograph, and detecting to obtain chromatograms of the single control solutions; then the sample solution is taken and injected into a liquid chromatograph for detection, a sample chromatogram is obtained, and the chromatographic conditions are as follows: a chromatographic column: an AQ-C18 column: 4.6 * 250 mm, 5 [mu] m; mobile phases: a mobile phase A is acetonitrile, a mobile phase B is a 0.025%-0.1% formic acid solution, and the ratio and flow velocity of the mobile phases change along with time; and (4) analyzing the chromatogram of the single control solution and the chromatogram of the sample by utilizing a traditional Chinese medicine chromatographic fingerprint spectrum similarity evaluation system 2012 to obtain a fingerprint spectrum. According to the fingerprint spectrum establishment method provided by the invention, the seven hydroxyl naphthoquinone components in the lithospermum erythrorhizon can be clearly separated.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of Chinese medicinal material identification, and in particular to a method for establishing an HPLC fingerprint of hydroxynaphthoquinone components of sclerophyll arborvitae and its application. Background Art

[0002] Lithospermum erythrorhizon is a traditional Chinese medicinal material. The traditional medicine is the plant Lithospermum erythrorhizon Sieb.et Zucc. of the Boraginaceae family. Lithospermum erythrorhizon is sweet, salty, cold, and belongs to the pericardium and liver meridians. It has the effects of cooling blood, promoting blood circulation, clearing away heat and detoxifying. Lithospermum erythrorhizon has the effects of anti-tumor, ovarian cancer prevention, antibacterial, antiviral, anti-inflammatory, and promoting granulation growth. It is mainly used to treat diseases such as warm-heat macules, damp-heat jaundice, purpura, vomiting, epistaxis, hematuria, stranguria and bloody dysentery, heat-induced constipation, burns, eczema, erysipelas, carbuncle, skin cancer, lupus erythematosus, herpes zoster, eczema, smallpox, measles, etc.

[0003] Naphthoquinones, benzoquinones, flavonoids, alkaloids and polysaccharides are the main active ingredients of Lithospermum officinale. Among them, the anti-cancer effect and strong lipid solubility of hydroxynaphthoquinone compounds are the main active ingredients of Lithospermum officinale, especially 7 ingredients such as L-shikonin, β-hydroxyisovalerylshikonin, acetyl akanin, deoxyshikonin, isobutyrylshikonin, β, β-dimethylacryloyl akanin and isovalerylshikonin are the main material components of Lithospermum officinale. Therefore, the fingerprint of Lithospermum officinale is established based on the main active ingredients and indicator components of Lithospermum officinale, which provides a more powerful basis for the quality evaluation and control of Lithospermum officinale, and also provides a basis for its identification.

[0004] However, the existing main analytical methods for Lithospermum erythrorhizon, such as thin layer scanning (TLC), UV-visible spectrophotometry, gas chromatography (GC), and liquid chromatography (HPLC), are all difficult to separate the main active ingredients of the above seven kinds of Lithospermum erythrorhizon and establish indicative detection standards, which makes it difficult to accurately judge and evaluate the quality of Lithospermum erythrorhizon. Summary of the invention

[0005] The present invention innovatively prepares a method for establishing and applying an HPLC fingerprint of hydroxynaphthoquinone components of sclerophyll. The method can separate and wash out 7 hydroxynaphthoquinone components in sclerophyll, and obtain a fingerprint that can qualitatively and quantitatively analyze the 7 hydroxynaphthoquinone components in sclerophyll, which is conducive to a more comprehensive and objective evaluation of the quality of sclerophyll.

[0006] The content of hydroxynaphthoquinone components in sclerophyll is relatively high, and it is also one of the main active ingredients that manifest its pharmacological effects. Therefore, judging the content of hydroxynaphthoquinone components in sclerophyll is one of the important indicators for judging the quality of sclerophyll. However, due to the wide variety of hydroxynaphthoquinone components in sclerophyll, the separation and washing methods provided in the prior art are difficult to wash out a variety of hydroxynaphthoquinone components separately. Therefore, it is difficult to determine which hydroxynaphthoquinone components that specifically play a major pharmacological effect are provided by which component or components, and it is also difficult to clarify the optimization of cultivation conditions. Therefore, separating and washing out as many hydroxynaphthoquinone components in sclerophyll as possible is an important technical prerequisite for evaluating and controlling the quality of sclerophyll.

[0007] To achieve the above object, the present invention intends to adopt the following technical solutions:

[0008] The present invention provides a method for establishing an HPLC fingerprint of hydroxynaphthoquinone components of sclerophyll pyrophyll, comprising the following steps:

[0009] (1) obtaining an extract and preparing a sample solution: providing sclerophyllium, and using petroleum ether as an extraction solvent to extract an extract; quantitatively taking the extract, and fixing the volume to obtain a sample solution;

[0010] (2) preparing single control solutions: preparing single control solutions of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin respectively;

[0011] (3) respectively injecting a single control solution into a liquid chromatograph for detection to obtain a chromatogram of the single control solution; and then injecting a sample solution into a liquid chromatograph for detection to obtain a sample chromatogram, wherein the chromatographic conditions include:

[0012] Chromatographic column: AQ-C18 column: 4.6×250mm, 5μm; Mobile phase: Mobile phase A is acetonitrile, mobile phase B is 0.025%-0.1% formic acid solution, the ratio and flow rate of the mobile phase change with time:

[0013]

[0014] (4) The chromatogram of the single control solution obtained in step (3) and the sample chromatogram are analyzed using the Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System 2012 to determine the characteristic peaks of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin, and obtain the HPLC fingerprint of shikonin.

[0015] Furthermore, in some embodiments of the present application, the solvent used to prepare the sample solution by volume, the solvent used to prepare the single sample solution, and the solvent used to prepare the mixed sample solution are the same as mobile phase A.

[0016] Furthermore, in some embodiments of the present application, the chromatographic conditions also include: detection wavelength: 271-328 nm; column temperature: 30-35°C.

[0017] Further, in some embodiments of the present application, the detection wavelength is 275 nm, the column temperature is 35° C., and the mobile phase B is 0.05% formic acid water.

[0018] Furthermore, in some embodiments of the present application, the concentration of the single sample solution of levorotatory shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, isovalerylshikonin and deoxyshikonin is 0.4 mg / mL; the concentration of the single sample solution of β-hydroxyisovalerylshikonin is 0.2 mg / mL.

[0019] Further, in some embodiments of the present application, the concentrations of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin in the mixed control solution are 0.04 mg / mL, 0.04 mg / mL, 0.04 mg / mL, 0.04 mg / mL, 0.02 mg / mL, 0.04 mg / mL and 0.04 mg / mL, respectively.

[0020] Further, in some embodiments of the present application, taking the characteristic peak of acetyl akanin as the base peak, the lithospermum HPLC fingerprint includes the characteristic peak of levorotatory shikonin, the characteristic peak of β-hydroxyisovaleryl shikonin, the characteristic peak of deoxyshikonin, the characteristic peak of isobutyryl shikonin, the characteristic peak of ββ-dimethylacryloyl akanin, and the characteristic peak of isovaleryl shikonin, and their relative retention times are:

[0021] The relative retention time of the characteristic peak of L-shikonin is: 0.6950~0.7000;

[0022] The relative retention time of β-hydroxyisovalerylshikonin is: 0.8400~0.8450;

[0023] The relative retention time of acetyl akanin is: 1.000;

[0024] The relative retention time of deoxyshikonin is: 1.3100-1.3150;

[0025] The relative retention time of isobutyrylshikonin is: 1.4730~1.4780;

[0026] The relative retention time of ββ-dimethylacryloyl akanin is: 1.9000~1.9150;

[0027] The relative retention time of isovalerylshikonin is 2.1550-2.1700.

[0028] In a second aspect, the present application also provides the application of the HPLC fingerprint of the hydroxynaphthoquinone components of Lithospermum officinale obtained above in the field of quality evaluation of Lithospermum officinale.

[0029] Further, in some embodiments of the present application, the application includes: comparing the HPLC spectrum of the extract of the lithospermum to be quality evaluated with the HPLC fingerprint spectrum of the lithospermum to determine whether the components of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin in the lithospermum are present; and calculating the contents of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin in the lithospermum to be quality evaluated according to the HPLC spectrum of the extract of the lithospermum to be quality evaluated.

[0030] The quality of the lithospermum to be evaluated is judged according to the contents of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin in the lithospermum.

[0031] The beneficial effects of the present invention are:

[0032] The method for establishing the HPLC fingerprint of hydroxynaphthoquinone components of sclerotium provided by the present invention adopts acetonitrile-formic acid as the mobile phase, and separates and washes out 7 hydroxynaphthoquinone components as the specific mobile phase changes, so that the contents of the 7 hydroxynaphthoquinone components in sclerotium can be qualitatively and quantitatively detected, and the multi-faceted detection of hydroxynaphthoquinone components in sclerotium can be realized, and its quality detection system can be improved, thereby providing a reliable basis for the authenticity identification and intrinsic quality of lithospermum. The HPLC fingerprint of hydroxynaphthoquinone components of sclerotium obtained by the method for establishing the HPLC fingerprint of hydroxynaphthoquinone components of sclerotium provided by the present invention is more complete and more accurate than the existing HPLC fingerprint of sclerotium, and is more conducive to promotion and application. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 The fingerprint of the sample solution of Lithospermum sclerosus obtained by the experimental method recorded in the 2020 edition of the Chinese Pharmacopoeia;

[0034] Figure 2The fingerprint of the sample solution of Lithospermum sclerotium obtained by the detection method disclosed in the existing patent CN108802220A;

[0035] Figure 3 The fingerprint spectrum is established by using the HPLC fingerprint spectrum establishment method of 7 hydroxynaphthoquinone components of Lithospermum sclerotium provided in this application;

[0036] Figure 4 This is a liquid chromatogram obtained by using the method for establishing HPLC fingerprints of 7 hydroxynaphthoquinone components of Lithospermum erythrorhizon provided in this application for 12 batches of Lithospermum erythrorhizon in the examples of this application. DETAILED DESCRIPTION

[0037] The technical scheme of the present invention will be further described in detail below in conjunction with specific embodiments. The following embodiments are only exemplary to illustrate and explain the present invention, and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.

[0038] The present invention provides a method for establishing an HPLC fingerprint of hydroxynaphthoquinone components of sclerophyll pyrophyll, comprising the following steps:

[0039] (1) obtaining an extract and preparing a sample solution: providing sclerophyllium, and using petroleum ether as an extraction solvent to extract an extract; quantitatively taking the extract, and fixing the volume to obtain a sample solution;

[0040] (2) preparing single control solutions: preparing single control solutions of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin respectively;

[0041] (3) respectively injecting a single control solution into a liquid chromatograph for detection to obtain a chromatogram of the single control solution; and then injecting a sample solution into a liquid chromatograph for detection to obtain a sample chromatogram, wherein the chromatographic conditions include:

[0042] Chromatographic column: AQ-C18 column: 4.6×250mm, 5μm; Mobile phase: Mobile phase A is acetonitrile, mobile phase B is 0.025%-0.1% formic acid solution, the ratio and flow rate of the mobile phase change with time:

[0043]

[0044]

[0045] (4) The chromatogram of the single control solution obtained in step (3) and the sample chromatogram are analyzed using the Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System 2012 to determine the characteristic peaks of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin, and obtain the HPLC fingerprint of shikonin.

[0046] Wherein, the sclerophyll lithospermum is provided in the form of powder, which can improve the extraction effect and make the effective ingredients more fully extracted. The amount of sclerophyll lithospermum powder used and the amount of extraction solvent used can be adjusted according to the amount of extract required to be extracted. Exemplarily, step (1) can be:

[0047] Accurately weigh 1.00g of lithospermum officinale powder, place in a stoppered conical flask, add analytical grade petroleum ether, place in a 60℃ water bath for 20-50min, perform ultrasonic extraction for 25-45min, place in a water bath for 30-60min again, cool, reweight, filter under reduced pressure, accurately measure 10ml of the filtrate, rotary evaporate, add chromatographic grade acetonitrile to dissolve, place in a 10ml volumetric flask to the fixed volume, and obtain a sample solution.

[0048] Preferably, 1.00 g of lithospermum officinale powder is accurately weighed and placed in a 50 ml conical flask with a stopper, analytical grade petroleum ether is added, the mixture is placed in a water bath at 60° C. for 30 min, ultrasonically extracted for 30 min, and then placed in a water bath for 40 min again, cooled, reweighted, and filtered under reduced pressure, 10 ml of the filtrate is accurately measured, rotary evaporated, chromatographic grade acetonitrile is added to dissolve, and the mixture is placed in a 10 ml volumetric flask to obtain a sample solution.

[0049] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments. Obviously, the described embodiments are part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0050] Example

[0051] This embodiment provides a method for establishing an HPLC fingerprint of hydroxynaphthoquinone components of sclerophyll, which specifically comprises the following steps:

[0052] (1) Obtain the extract and prepare the sample solution:

[0053] Weigh 1.00g of Lithospermum officinale powder, accurately weigh it, put it into a 50ml conical flask with a stopper, accurately add 50ml of 60℃ analytical pure petroleum ether, water bath at 60℃ for 30min, ultrasonic extraction (1000w, 40kHz) for 30min, water bath for 40min, cool, reweight, filter under reduced pressure, accurately measure 10ml of the filtrate, rotary evaporate, add chromatographic pure acetonitrile to dissolve, put it into a 10ml volumetric flask to make up to volume, and obtain a sample solution. According to the above preparation method, 12 batches of sample solutions of Lithospermum officinale samples were prepared and set aside.

[0054] (2) Prepare a single control solution:

[0055] Accurately weigh (using an electronic balance) 10 mg each of L-shikonin, acetyl akanin, isobutyrylshikonin, β-β-dimethylacryloyl akanin, isovalerylshikonin and deoxyshikonin, and accurately weigh 5 mg of β-hydroxyisovalerylshikonin, respectively place each reference substance component in a 25 ml volumetric flask, add chromatographic pure acetonitrile to make up to 25 ml, and obtain a reference substance solution.

[0056] (3) respectively injecting a single control solution into a liquid chromatograph for detection to obtain a chromatogram of the single control solution; and then injecting a sample solution into a liquid chromatograph for detection to obtain a sample chromatogram, wherein the chromatographic conditions include:

[0057] Chromatographic column: AQ-C18 column, particle size 5μm, specification 4.6×250mm; mobile phase: mobile phase A is acetonitrile, mobile phase B is 0.05% formic acid solution, mobile phase content and flow rate gradient elution is adopted, detection wavelength: 275nm; column temperature: 35℃; injection volume: 10μL;

[0058] The mobile phase content and flow rate changes are shown in Table 1.

[0059] Table 1

[0060]

[0061] (4) Establishment of fingerprint

[0062] The HPLC fingerprints of 12 batches of Lithospermum officinale were determined and compared with the chromatograms of a single reference solution to obtain a HPLC standard fingerprint of Lithospermum officinale consisting of their common peaks (see Appendix Figure 2 , 3, 4), wherein peak 5 is taken as the reference peak, and the relative retention times tR (means) of the 12 common peaks in the standard fingerprint are calculated to be 0.6594, 0.6993, 0.7448, 0.8437, 1.000, 1.1971, 1.2568, 1.3140, 1.5210, 1.9074, 2.1603; the relative peak areas (means) are 0.5525, 5.4650, 0.4683, 12.4100, 36.1800, 0.3392, 1.3800, 1.5633, 23.1392, 3.8117, 12.6075.

[0063] It is obtained that peak 2 is the characteristic peak of L-shikonin, peak 4 is the characteristic peak of β-hydroxyisovalerylshikonin, peak 5 is the characteristic peak of acetyl akanin, peak 8 is the characteristic peak of deoxyshikonin, peak 9 is the characteristic peak of isobutyrylshikonin, peak 10 is the characteristic peak of β,β-dimethylacryloyl akanin, and peak 11 is the characteristic peak of isovalerylshikonin.

[0064] Table 2

[0065] Serial number 1 2 3 4 5 6 7 8 9 10 11 S1 0.6593 0.6995 0.7451 0.8438 1.0000 1.1977 1.2575 1.3148 1.4878 1.9125 2.1652 S2 0.6576 0.6972 0.7430 0.8416 1.0000 1.1944 1.2538 1.3109 1.4966 1.9058 2.1582 S3 0.6585 0.6988 0.7439 0.8429 1.0000 1.1972 1.2574 1.3148 1.4843 1.9119 2.1649 S4 0.6593 0.6993 0.7447 0.8439 1.0000 1.1969 1.2574 1.3139 1.4962 1.9038 2.1565 S5 0.6595 0.6995 0.7447 0.8438 1.0000 1.1971 1.2570 1.3138 1.4971 1.9045 2.1575 S6 0.6600 0.6999 0.7451 0.8440 1.0000 1.1977 1.2576 1.3148 1.4969 1.9069 2.1605 S7 0.6598 0.6996 0.7451 0.8439 1.0000 1.1978 1.2571 1.3146 1.4978 1.9072 2.1602 S8 0.6600 0.6999 0.7450 0.8442 1.0000 1.1975 1.2572 1.3143 1.4976 1.9074 2.1603 S9 0.6598 0.6996 0.7453 0.8438 1.0000 1.1972 1.2565 1.3139 1.4979 1.9066 2.1596 S10 0.6598 0.6996 0.7453 0.8438 1.0000 1.1972 1.2569 1.3139 1.4975 1.9070 2.1596 S11 0.6598 0.6996 0.7451 0.8439 1.0000 1.1974 1.2567 1.3133 1.4965 1.9067 2.1594 S12 0.6598 0.6996 0.7453 0.8442 1.0000 1.1977 1.2569 1.3144 1.4979 1.9083 2.1613

[0066] The HPLC fingerprints of 12 batches of Lithospermum officinale were imported into the "Chinese Herbal Medicine Chromatographic Fingerprint Similarity Evaluation System 2012 Edition" for chromatographic peak matching. Peak 5 was used as a reference to determine the 11 common peaks as the common peaks constituting the Lithospermum officinale fingerprint. The relative retention times of the common peaks of the 12 batches of Lithospermum officinale are shown in Table 2, and the relative peak areas are shown in Table 3. Figure 4 .

[0067] Table 3

[0068] Serial number 1 2 3 4 5 6 7 8 9 10 11 S1 0.55 5.44 0.47 12.43 36.24 0.34 1.38 1.57 23.15 3.87 12.43 S2 0.55 5.47 0.47 12.37 36.04 0.34 1.39 1.56 23.09 3.82 12.39 S3 0.55 5.48 0.47 12.55 36.65 0.34 1.36 1.54 23.41 3.79 12.82 S4 0.56 5.44 0.47 12.40 36.18 0.34 1.37 1.56 23.15 3.83 12.59 S5 0.55 5.45 0.47 12.39 36.23 0.34 1.38 1.58 23.16 3.82 12.59 S6 0.55 5.46 0.47 12.40 36.06 0.34 1.37 1.57 23.17 3.82 12.60 S7 0.55 5.47 0.46 12.39 36.21 0.34 1.38 1.57 23.13 3.82 12.68 S8 0.55 5.48 0.47 12.40 36.18 0.34 1.38 1.56 23.10 3.81 12.65 S9 0.55 5.47 0.47 12.43 36.24 0.33 1.38 1.57 23.10 3.77 12.58 S10 0.55 5.47 0.46 12.39 36.11 0.34 1.39 1.56 23.07 3.80 12.66 S11 0.56 5.47 0.47 12.38 35.86 0.34 1.39 1.56 23.07 3.80 12.65 S12 0.56 5.48 0.47 12.39 36.16 0.34 1.39 1.56 23.07 3.79 12.65

[0069] As can be seen from the above table, the separation and elution effect of the seven hydroxynaphthoquinone components in Sclerophyllium established by the fingerprint establishment method provided in the present application is better, and the various hydroxynaphthoquinone components in Sclerophyllium can be better separated and their contents can be quantitatively analyzed, which is conducive to a more accurate evaluation of the quality of Sclerophyllium and provides effective data support for the quality optimization of Sclerophyllium.

[0070] Among them, the liquid chromatography used is obtained by a high performance liquid chromatograph. The model of the high performance liquid chromatograph selected in this embodiment is the Thermo Fisher Ultimate 3000 high performance liquid chromatograph (Thermo Fisher Scientific, USA), and the instrument used for precise weighing is an AG135 electronic analytical balance (METTLER TOLEDO, Switzerland); the ultrasonic equipment in the extraction process is a KS-500DE liquid crystal ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); the constant temperature equipment used in the extraction process is a HH-4 digital display constant temperature water bath (Changzhou Jintan Youlian Instrument Research Institute).

[0071] The L-shikonin, acetylakanin, isobutyrylshikonin, ββ-dimethylacryloylshikonin, isovalerylshikonin, deoxyshikonin, and β-hydroxyisovalerylshikonin used in the single control sample were all purchased from Pusi Biotechnology. The mobile phases used were all chromatographically pure, the petroleum ether used to extract the sample solution was analytically pure, and the water used was ultrapure water.

[0072] The lithospermum samples used in the examples were collected from different areas in the wild, and were identified as Lithospermum erythrorhizon Sieb.et Zucc. of the Boraginaceae family. The batch numbers of the lithospermum erythrorhizon used in the test samples are shown in Table 4.

[0073] Table 4

[0074]

[0075] In order to further verify the stability, reproducibility and precision of the fingerprint establishment method provided in this application.

[0076] Stability test:

[0077] The inventor randomly sampled Lithospermum officinale (batch number: YZC230809), prepared a sample solution according to the method disclosed in step (1) of the above embodiment, and injected the sample at 0h, 2h, 4h, 8h, 12h, and 24h, respectively. Peak 5 was used as the reference peak, and the relative retention time RSD values ​​of common peaks 1 to 11 were calculated to be less than 1%, and the relative peak area RSD values ​​were all less than 2%. At the same time, the similarity of each chromatographic fingerprint calculated by similarity evaluation software was greater than 0.9, indicating that the sample solution was stable within 24h.

[0078] Reproducibility experiment

[0079] The inventor took 6 portions of the same batch of Lithospermum officinale (batch number: YZC230809), accurately measured them respectively, prepared sample solutions according to the method disclosed in step (1) of the embodiment, and injected them respectively to obtain spectra. Taking peak No. 5 as the reference peak, the relative retention time RSD values ​​of common peaks No. 1 to No. 11 were calculated to be less than 1%, and the relative peak area RSD values ​​were all less than 2%. At the same time, the similarity of each chromatographic fingerprint calculated by similarity evaluation software was greater than 0.99, indicating that the method had good reproducibility.

[0080] Accuracy experiment

[0081] The inventors took the same batch of samples of Lithospermum officinale (batch number: YZC230809), prepared a sample solution according to the method disclosed in step (1) of the embodiment, injected the sample 6 times continuously, took peak No. 5 as the reference peak, calculated that the relative retention time RSD value of common peaks No. 1 to No. 11 was less than 1%, and the relative peak area RSD value was less than 3%. At the same time, the similarity of each chromatographic fingerprint calculated by the "Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System 2012 Edition" software was greater than 0.9, indicating that the fingerprint obtained by this method and instrument has good stability and good accuracy.

[0082] In order to verify the fingerprint map provided in this application, the inventor also used the fingerprint map establishment method of Lithospermum officinale provided in the 2020 edition of the "Chinese Pharmacopoeia" as a comparative example for comparison.

[0083] The chromatographic conditions used in the 2020 edition of the Chinese Pharmacopoeia are octadecyl bonded silica gel as the filler; acetonitrile-water-formic acid (70:30:0.05) as the mobile phase; and the detection wavelength is 275 nm. The preparation methods of the sample solution and the single control solution are the same as those in the example, and will not be described in detail here.

[0084] The flow rate and ratio of the mobile phase are shown in Table 5.

[0085] Table 5

[0086]

[0087] The sample solution and the single reference solution identical to those in the example were tested in a high performance liquid chromatograph according to the above chromatographic conditions. The resulting fingerprint had 10 common peaks. Peak No. 4 was used as a reference peak. The relative retention time and relative peak area of ​​each common peak were calculated. The chemical components of the peaks in the reference fingerprint were annotated according to the retention time of the chromatogram of the mixed reference solution. The relative retention time of the common peaks was t RThey are: 0.7654, 0.7967, 0.8202, 1, 1.2188, 1.5799, 1.6767, 2.0226, 2.3321, 2.5300; the relative peak areas are: 0.35, 2.94, 1.96, 11.97, 38.89, 1.21, 1.34, 21.65, 3.77, 12.19; the separation degrees are: 1.09, na, na, na, na, 1.85, na, 3.26, 2.73, 8.79.

[0088] It can be seen that it is difficult to separate the 7 hydroxynaphthoquinone components using the experimental method disclosed in the 2020 edition of the "Chinese Pharmacopoeia", and it is impossible to obtain all the characteristic peaks of the 7 hydroxynaphthoquinone components. Therefore, it is impossible to establish the fingerprint spectrum of the 7 hydroxynaphthoquinone components in Lithospermum officinale.

[0089] In addition, the inventors also established the fingerprint of the hydroxynaphthoquinone components in Lithospermum officinale based on the detection method disclosed in the existing patent CN108802220A. The chromatographic conditions used are as follows: Chromatographic column: C 18 ; Mobile phase A: acetonitrile; Mobile phase B: 0.05% acetic acid aqueous solution; Mobile phase flow rate: 1.0 mL / min; Injection volume: 10 μl; Detection wavelength: 275 nm. The preparation methods of the sample solution and the single control solution are the same as those in the embodiment and will not be described in detail here.

[0090] The flow rate and ratio of the mobile phase are shown in Table 6.

[0091] Table 6

[0092]

[0093] The obtained fingerprint spectrum has 10 common peaks. The relative retention time and relative peak area of ​​each common peak are calculated with peak No. 4 as the reference peak. The chemical components of the peaks in the reference fingerprint spectrum are annotated according to the retention time of the chromatogram of the mixed reference solution. The relative retention time of the common peak is t R They are: 0.7664, 0.7982, 0.8204, 1, 1.2171, 1.5651, 1.6598, 2.0095, 2.3198, 2.5195; the relative peak areas are: 0.42, 2.54, 2.13, 11.95, 36.33, 1.38, 2.13, 23.32, 4, 12.97; the separation degrees are: 1.06, na, na, na, na, 1.83, na, 3.2, 2.73, 12.56.

[0094] It can be seen that it is difficult to separate the seven hydroxynaphthoquinone components using the experimental method disclosed in the patent CN108802220A, and it is also impossible to obtain all the characteristic peaks of the seven hydroxynaphthoquinone components. Therefore, it is impossible to establish the fingerprint spectrum of the seven hydroxynaphthoquinone components in Lithospermum sclerotium.

[0095] The fingerprint established by the present invention and the experimental method disclosed in the 2020 edition of the Chinese Pharmacopoeia and the patent CN108802220A is shown in Figure 1 to Figure 3 .

[0096] Although the present invention has been described in detail through the above embodiments, the above description is only to enable those familiar with the present technology to more easily understand the present invention, and does not limit the scope of implementation of the present invention. Therefore, all equivalent changes and modifications based on the shape, structure, characteristics and spirit described in the claims of the present invention are still within the scope of the present invention.

Claims

1. A method for establishing an HPLC fingerprint of hydroxynaphthoquinone components of Lithospermum officinale, characterized in that: The following steps are involved: (1) obtaining an extract and preparing a sample solution: providing sclerophyllium, and using petroleum ether as an extraction solvent to extract an extract; quantitatively taking the extract, and fixing the volume to obtain a sample solution; (2) preparing single control solutions: preparing single control solutions of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin respectively; (3) injecting a single reference solution into a liquid chromatograph for detection to obtain a chromatogram of the single reference solution; Then the sample solution is injected into a liquid chromatograph for detection to obtain a sample chromatogram, and the chromatographic conditions include: Chromatographic column: AQ-C18 column: 4.6×250mm, 5μm; Mobile phase: Mobile phase A is acetonitrile, mobile phase B is 0.025%-0.1% formic acid solution, the ratio and flow rate of the mobile phase change with time: (4) The chromatogram of the single control solution obtained in step (3) and the sample chromatogram are analyzed using the Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System 2012 to determine the characteristic peaks of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin, and obtain the HPLC fingerprint of shikonin.

2. The method for establishing the HPLC fingerprint of hydroxynaphthoquinone components of sclerophyll pyriferum according to claim 1, characterized in that: The solvent used for constant volume to obtain the sample solution, the solvent used for preparing the single sample solution, and the solvent used for preparing the mixed sample solution are the same as the mobile phase A.

3. The method for establishing the HPLC fingerprint of hydroxynaphthoquinone components of sclerophyll 1 according to claim 1, characterized in that: The chromatographic conditions also include: detection wavelength: 271-328 nm; column temperature: 30-35°C.

4. The method for establishing the HPLC fingerprint of hydroxynaphthoquinone components of sclerophyll thunbergii according to claim 3, characterized in that: The detection wavelength was 275 nm, the column temperature was 35° C., and the mobile phase B was 0.05% formic acid in water.

5. The method for establishing the HPLC fingerprint of hydroxynaphthoquinone components of sclerophyll 1 according to claim 1, characterized in that: The concentration of the single sample solution of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, isovalerylshikonin and deoxyshikonin is 0.4 mg / mL; the concentration of the single sample solution of β-hydroxyisovalerylshikonin is 0.2 mg / mL.

6. The method for establishing the HPLC fingerprint of hydroxynaphthoquinone components of sclerophyll 1 according to claim 1, characterized in that: The concentrations of L-shikonin, acetyl akanin, isobutyrylshikonin, β-β-dimethylacryloyl akanin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin in the mixed control solution are 0.04 mg / mL, 0.04 mg / mL, 0.04 mg / mL, 0.04 mg / mL, 0.02 mg / mL, 0.04 mg / mL and 0.04 mg / mL, respectively.

7. The method for establishing the HPLC fingerprint of hydroxynaphthoquinones of sclerophyll according to any one of claims 1 to 6, characterized in that: Taking the characteristic peak of acetyl akanin as the base peak, the lithospermum HPLC fingerprint includes the characteristic peak of levorotatory shikonin, the characteristic peak of β-hydroxyisovaleryl shikonin, the characteristic peak of deoxyshikonin, the characteristic peak of isobutyryl shikonin, the characteristic peak of ββ-dimethylacryloyl akanin, and the characteristic peak of isovaleryl shikonin, and their relative retention times are: The relative retention time of the characteristic peak of L-shikonin is: 0.6950~0.7000; The relative retention time of β-hydroxyisovalerylshikonin is: 0.8400~0.8450; The relative retention time of acetyl akanin is: 1.000; The relative retention time of deoxyshikonin is: 1.3100-1.3150; The relative retention time of isobutyrylshikonin is: 1.4730~1.4780; The relative retention time of ββ-dimethylacryloyl akanin is: 1.9000~1.9150; The relative retention time of isovalerylshikonin is 2.1550-2.1700.

8. Application of the HPLC fingerprint of hydroxynaphthoquinone components of Lithospermum sclerotium obtained according to any one of claims 1 to 7 in the field of quality evaluation of Lithospermum sclerotium.

9. The use according to claim 8, characterized in that: The HPLC spectrum of the extract of the lithospermum to be evaluated for quality is compared with the HPLC fingerprint of the lithospermum to determine whether the components of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin in the lithospermum are present; and according to the HPLC spectrum of the extract of the lithospermum to be evaluated for quality, the contents of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin in the lithospermum to be evaluated for quality are calculated. The quality of the lithospermum to be evaluated is judged according to the contents of L-shikonin, acetylakanin, isobutyrylshikonin, β-β-dimethylacryloylshikonin, β-hydroxyisovalerylshikonin, isovalerylshikonin and deoxyshikonin in the lithospermum.